| Product Code: ETC7661687 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to rely on imports for antimicrobial medication to combat sexually transmitted diseases, with top exporters being Switzerland, UK, Belgium, USA, and Germany. The market remained fairly diversified with low concentration, indicated by the low Herfindahl-Hirschman Index (HHI). Despite a slight decline in the compound annual growth rate (CAGR) from 2020-24 at -2.14%, the negative growth rate of -0.41% from 2023-24 suggests potential stabilization or slight recovery in the market. Israel`s import trends reflect a continued need for international partnerships to address public health challenges effectively.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Sexually Transmitted Diseases Antimicrobial Medication Market - Industry Life Cycle |
3.4 Israel Sexually Transmitted Diseases Antimicrobial Medication Market - Porter's Five Forces |
3.5 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of sexually transmitted diseases in Israel |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in antimicrobial medications for sexually transmitted diseases |
4.3 Market Restraints |
4.3.1 Stigma associated with sexually transmitted diseases leading to underreporting |
4.3.2 High cost of antimicrobial medications |
4.3.3 Regulatory challenges in the approval process for new medications |
5 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Trends |
6 Israel Sexually Transmitted Diseases Antimicrobial Medication Market, By Types |
6.1 Israel Sexually Transmitted Diseases Antimicrobial Medication Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Antiviral / Antiretrovirals, 2022 - 2032F |
6.1.4 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Antibiotics, 2022 - 2032F |
6.1.5 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Vaccines, 2022 - 2032F |
6.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Hospital, 2022 - 2032F |
6.2.3 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.2.4 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenues & Volume, By Others, 2022 - 2032F |
7 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Import-Export Trade Statistics |
7.1 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Export to Major Countries |
7.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Imports from Major Countries |
8 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Key Performance Indicators |
8.1 Number of reported cases of sexually transmitted diseases |
8.2 Adoption rate of new antimicrobial medications |
8.3 Rate of successful treatment outcomes |
8.4 Level of healthcare provider education and training on sexually transmitted diseases |
8.5 Research and development investment in new antimicrobial medications |
9 Israel Sexually Transmitted Diseases Antimicrobial Medication Market - Opportunity Assessment |
9.1 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Israel Sexually Transmitted Diseases Antimicrobial Medication Market - Competitive Landscape |
10.1 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Revenue Share, By Companies, 2025 |
10.2 Israel Sexually Transmitted Diseases Antimicrobial Medication Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here